Prosecution Insights
Last updated: November 04, 2026

Palani LLC

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Palani LLC is currently managing 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This activity is limited to 1 distinct examiner and 1 distinct art unit, reflecting a specific technical and procedural focus. The Biotechnology & Pharmaceuticals area often involves complex biological data, and the concentration in 1 distinct art unit suggests a specialized application of these technologies.

The busiest examiner for this portfolio is NEAGU, IRINA, who is responsible for 1 pending. As the only examiner currently engaged with the company's pending workload, the prosecution timeline is dependent on the specific review pace of this individual. This creates a direct line of communication between the applicant and the examiner, simplifying the negotiation process for the pending matter.

With 1 pending office action, the portfolio does not face the challenges of managing multiple simultaneous responses. The use of 1 distinct art unit means that the applicant can focus on the specific examination standards and prior art landscape relevant to that unit. Practitioners should carefully review the specific objections raised by NEAGU, IRINA to ensure a comprehensive response that addresses all concerns in the Biotechnology & Pharmaceuticals space.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
0
Final Rejections
1
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
NEAGU, IRINA 1 46.8% +57.2%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17998161 A FATTY ACID BASED COMPOSITION FOR TREATMENT AND/OR PREVENTION OF ENVELOPED-VIRUS RELATED INFECTIONS NEAGU, IRINA —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17998161 A FATTY ACID BASED COMPOSITION FOR TREATMENT AND/OR PREVENTION OF ENVELOPED-VIRUS RELATED INFECTIONS NEAGU, IRINA —

Top Art Units

Art UnitApps
1629 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
17998161 A FATTY ACID BASED COMPOSITION FOR TREATMENT AND/OR PREVENTION OF ENVELOPED-VIRUS RELATED INFECTIONS NEAGU, IRINA 1629 §102§103§112 Non-Final OA — Pending Nov 08, 2022

Managing Palani LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Palani LLC have?

Palani LLC has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Palani LLC applications?

Irina Neagu has the most, with 1 of Palani LLC's pending office actions.

What technology area are Palani LLC's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month